Stay updated on Regorafenib Pembrolizumab CRC Clinical Trial
Sign up to get notified when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.

Latest updates to the Regorafenib Pembrolizumab CRC Clinical Trial page
- Check5 days agoChange DetectedThe page’s software/display revision was updated from v3.5.2 to v3.5.3, indicating a minor update to the site version without changing the underlying study details.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-visible content or functionality changes are introduced.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No changes to study data, eligibility criteria, or results.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.4.3 was added to the page. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision on the page updates from v3.4.0 to v3.4.1 with no visible changes to the study content or essential page sections. The update appears to be an internal site version change rather than alterations to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Regorafenib Pembrolizumab CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib Pembrolizumab CRC Clinical Trial page.